
Acute leukemia: pushing boundaries in disease management
VJHemOnc Podcast
00:00
CAR T Cell Therapy for Relapse and Refractory ALL: Outcomes and Toxicities
An in-depth discussion on the outcomes and toxicities of CAR T cell therapy for patients with relapse and refractory acute lymphoblastic leukemia, including the development of a new grading scheme for neurologic toxicity assessment.
Transcript
Play full episode